Clinical Trial Update: Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetics trial of antiplatelet drugs in diabetic patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Diabetes | Phase 4 | Status: WITHDRAWN